CAMYLOFIN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Name: Camylofin Market News
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy
Keywords: Camylofin Market Size, Camylofin Market Share, Camylofin Market Trends, Camylofin Market Growth, Camylofin Market Analysis, Camylofin Market Forecast, Camylofin Market Report, Camylofin Industry Report

Camylofin Market, By Indication (Muscle Spasm and Renal Colic), By Formulation (Oral, Parenteral, and Others), By End User (Hospitals, Specialty Clinics, Home Care, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Sep 2024
Code : CMI7418
Pages :140
Formats :
Excel and PDF
Industry : Pharmaceutical

Key Developments

On 23 August 2024, The Indian government has banned 156 fixed-dose combination (FDC) drugs, including Camylofin Dihydrochloride 25 mg + Paracetamol 300 mg. This decision was made due to concerns that these combinations pose a risk to human health and lack therapeutic justification. The ban is part of a broader regulatory effort to ensure drug safety and efficacy, following recommendations from an expert committee and the Drugs Technical Advisory Board (DTAB).